• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Valeant Rejected Takeda Bid

Article

May 27, 2016.

Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.

The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.

More on the story here.

 

Recent Videos